Marcus Sucksdorff
Publications
- Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging (2020)
- Neurology, Neuroimmunology and Neuroinflammation
(A1 Refereed original research article in a scientific journal) - Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland (2020)
- Multiple Sclerosis and Related Disorders
(A1 Refereed original research article in a scientific journal) - Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [C-11]PBR28 HRRT PET study (2019)
- European Journal of Nuclear Medicine and Molecular Imaging
(A1 Refereed original research article in a scientific journal) - Natalizumab treatment reduces microglial activation in the white matter of the MS brain (2019)
- Neurology, Neuroimmunology and Neuroinflammation
(A1 Refereed original research article in a scientific journal) - Rituksimabi MS-taudin hoidossa (2019)
- Duodecim
(A1 Refereed original research article in a scientific journal) - Microglial activation, white matter tract damage, and disability in MS (2018)
- Neurology, Neuroimmunology and Neuroinflammation
(A1 Refereed original research article in a scientific journal) - Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis (2017)
- Journal of Nuclear Medicine
(A1 Refereed original research article in a scientific journal) - Kuvantaminen MS-taudissa (2015)
- Lääkärilehti
(A2 Refereed review article in a scientific journal ) - Microglial activation correlates with disease progression in multiple sclerosis (2015) E. Rissanen, J. Tuisku, M. Gardberg, A.M. Dickens, M. Sucksdorff, J. Rokka, T. Paavilainen, R. Parkkola, J.O. Rinne, L. Airas
(Other publication) - Brain positron emission tomography scanning can be used to image pathological determinants of progressive multiple sclerosis (2014)
- Multiple Sclerosis
(Other publication)